COGNYXX
PHARMACEUTICALS
Home
About
Approach
Pipeline
Publications
Contact
More
A novel monoclonal antibody targeting aggregated transthyretin facilitates its removal and functional recovery in an experimental model
Dual Targeting of Soluble Oligomeric and Aggregated Transthyretin with a Monoclonal Antibody Ameliorates Experimental Neuropathy
A functional role for spontaneously occurring natural anti-transthyretin antibodies from patients with transthyretin cardiac amyloidosis